抑制PARP-1会增加Ets-1-表达MDA-MB-231乳腺癌细胞中的氧化应激
Magalie Hervieu1,2, Arnaud J Legrand1,2, Emilie Floquet1,2
1CNRS EMR9002 Integrative Structural Biology, Lille, France.
Cancer reports (Hoboken, N.J.)
|January 8, 2025
概括
聚 ((ADP-ribose) 聚合酶-1 (PARP-1) 抑制剂通过增加氧化应激和DNA损伤来降低乳腺癌细胞的生长,特别是在表达Ets-1的细胞中. 这种机制突出了针对癌症治疗的有针对性的方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 转录因子Ets-1对于癌症的进展至关重要.
- 聚ADP-ribose) 聚合酶-1 (PARP-1) 抑制会增加Ets-1水平,导致癌细胞死亡.
研究的目的:
- 研究Ets-1-表达乳腺癌细胞中PARP-1抑制的抗瘤机制.
- 阐明Ets-1在PARP-1抑制剂诱导的细胞效应中的作用.
主要方法:
- 已经测试了四种PARP抑制剂 (PJ-34,Veliparib,Olaparib,Rucaparib).
- 评估细胞生长,细胞循环停止 (G2/M阶段).
- 评估了Ets-1-过度表达与非表达细胞中的氧化DNA损伤,活性氧物种 (ROS) 生产和p47phox表达.
主要成果:
- PARP 抑制剂通过 G2/M 细胞循环停止来减少细胞生长.
- PARP 抑制剂诱导了氧化 DNA 损伤,并特别在 Ets-1-过度表达细胞中触发了 DNA 损伤反应.
- PARP 抑制剂增加了Ets-1-过度表达细胞中的ROS和p47phox表达.
结论:
- 抑制PARP-1引起的氧化DNA损伤和氧化压力与乳腺癌细胞中的Ets-1表达相关.
- 这些研究结果表明,潜在的治疗策略是针对表达Ets-1的癌症.
相关概念视频
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:37DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
01:23Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
01:46Electron Transport Chain: Complex I and II
11.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.1K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K